X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1727) 1727
Publication (74) 74
Book Chapter (58) 58
Book Review (51) 51
Book / eBook (50) 50
Magazine Article (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (885) 885
female (527) 527
index medicus (390) 390
drug-induced lupus (372) 372
male (307) 307
adult (276) 276
middle aged (231) 231
medicine & public health (215) 215
risk factors (192) 192
systemic lupus erythematosus (187) 187
animals (186) 186
pharmacology/toxicology (165) 165
rheumatology (161) 161
drug safety and pharmacovigilance (158) 158
lupus erythematosus, systemic - chemically induced (158) 158
lupus (157) 157
complications and side effects (142) 142
aged (134) 134
rheumatoid-arthritis (120) 120
case studies (119) 119
chemical and drug induced liver injury - etiology (119) 119
pregnancy (117) 117
systemic-lupus-erythematosus (115) 115
drug therapy (113) 113
immunology (105) 105
lupus erythematosus, systemic - drug therapy (104) 104
autoimmunity (103) 103
lupus erythematosus, systemic - immunology (103) 103
drugs (102) 102
pharmacology & pharmacy (101) 101
toxicology (97) 97
therapy (93) 93
dermatology (92) 92
adolescent (89) 89
autoantibodies (89) 89
systemic-lupus-erythematosus, drug-induced (88) 88
disease (84) 84
erythematosus (84) 84
lupus, drug-induced (84) 84
mice (84) 84
medicine, general & internal (81) 81
infliximab (79) 79
liver (72) 72
care and treatment (69) 69
antibodies (67) 67
diagnosis (65) 65
elderly (65) 65
rheumatoid arthritis (65) 65
immunological-disorders, drug-induced (63) 63
gastroenterology & hepatology (62) 62
chemical and drug induced liver injury (59) 59
chemical and drug induced liver injury - pathology (58) 58
dna methylation (57) 57
research (56) 56
treatment outcome (56) 56
tumor necrosis factor-alpha - antagonists & inhibitors (56) 56
abnormalities, drug-induced - etiology (55) 55
dosage and administration (55) 55
lupus erythematosus, systemic - complications (55) 55
health aspects (54) 54
abnormalities, drug-induced (53) 53
autoimmune diseases (53) 53
child (53) 53
diagnosis, differential (53) 53
immunosuppressive agents - adverse effects (53) 53
systemic lupus-erythematosus (53) 53
hepatitis (52) 52
infant, newborn (52) 52
lupus erythematosus, systemic - diagnosis (52) 52
drug-induced lupus erythematosus (51) 51
liver - pathology (51) 51
lupus erythematosus (50) 50
anti-bacterial agents - adverse effects (49) 49
hepatotoxicity (49) 49
antinuclear antibodies (48) 48
etanercept (47) 47
immunosuppressive agents - therapeutic use (46) 46
side effects (46) 46
antibodies, monoclonal - adverse effects (45) 45
arthritis, rheumatoid - drug therapy (45) 45
procainamide (45) 45
antirheumatic agents - adverse effects (44) 44
biopsy (44) 44
liver diseases (44) 44
adalimumab (43) 43
hydralazine (43) 43
necrosis-factor-alpha (42) 42
drug-induced (41) 41
drug-related side effects and adverse reactions (41) 41
liver - drug effects (41) 41
liver function tests (41) 41
pregnancy complications - drug therapy (41) 41
autoimmune hepatitis (40) 40
disease models, animal (40) 40
medicine (40) 40
musculoskeletal-disorders, drug-induced (40) 40
abridged index medicus (39) 39
article (39) 39
minocycline - adverse effects (39) 39
t-cells (39) 39
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (39) 39
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Online Resources - Online (2) 2
Pharmacy (2) 2
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reference (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Reference (1) 1
Knox College (Caven) - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Robarts - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1661) 1661
Japanese (55) 55
French (46) 46
German (22) 22
Chinese (11) 11
Korean (9) 9
Spanish (9) 9
Czech (6) 6
Portuguese (6) 6
Italian (4) 4
Polish (4) 4
Dutch (3) 3
Russian (3) 3
Hungarian (2) 2
Turkish (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 10/2014, Volume 131, Issue 2, pp. 149 - 156
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | RHEUMATOID-ARTHRITIS | AUTOANTIBODIES | NECROSIS-FACTOR-ALPHA | INDUCTION | DERMATOLOGY | Anti-TNF alpha-induced lupus | THERAPY | AUTOIMMUNITY | INFLIXIMAB | ETANERCEPT | ANTI-TNF-ALPHA | EPIDEMIOLOGY | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2010, Volume 10, Issue 1, pp. 46 - 50
Abstract Purpose To review and update drug-induced lupus (DIL) with emphasis on the characteristics of anti-TNF-induced lupus. Results DIL is an autoimmune... 
Allergy and Immunology | Autoimmunity | Anti-TNF | Drug-induced lupus | SLE | Biologics | Lupus | Systemic lupus erythematosus | Rheumatoid arthritis
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 01/2017, Volume 281, Issue 1, pp. 52 - 64
Journal Article
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 06/2018, Volume 30, Issue 5, pp. 490 - 497
PURPOSE OF REVIEWRapid introduction of newly developed drugs in the absence of clear understanding of the pathophysiologic mechanisms behind drug-induced lupus... 
drugs | ACETYLATOR PHENOTYPE | ANTINUCLEAR ANTIBODIES | RHEUMATOLOGY | ANTITUMOR NECROSIS FACTOR | INDUCED AUTOIMMUNITY | autoimmunity | drug-induced lupus erythematosus | DNA METHYLTRANSFERASE | CASE SERIES | SYNGENEIC MICE | OF-THE-LITERATURE | mechanisms | ANTI-TNF-ALPHA | T-CELLS
Journal Article